Skip to main content
. Author manuscript; available in PMC: 2015 Feb 25.
Published in final edited form as: Am J Transplant. 2014 Jul 1;14(9):2081–2087. doi: 10.1111/ajt.12783

Table 3.

Multistate Cox regression model comparing the risk of death of POPH MELD exception point recipients to non-POPH, nonexception waitlist candidates from the time of listing/receiving exception points

Variable Multivariable HR p-Value1
Nonexception waitlist
 candidates, n=34 180
1
POPH MELD exceptions
 with hemodynamic criteria
 consistent with POPH,
 n=100
2.46 (1.73–3.52) <0.001
POPH MELD exceptions
 without hemodynamic
 criteria consistent with
 POPH, n=55
1.60 (1.04–2.47) 0.03
Male gender 0.91 (0.85–0.98) 0.01
Race/ethnicity <0.001
 White 1
 Black 1.00 (0.90–1.10)
 Hispanic 0.93 (0.85–1.03)
 Asian 0.94 (0.82–1.08)
 Other 0.89 (0.74–1.07)
Age at listing 1.36 (1.32–1.39) <0.001
Primary diagnosis <0.001
 Hepatitis C 1
 Alcohol 0.74 (0.70–0.78)
 Hepatitis B 0.66 (0.57–0.76)
 NASH/cryptogenic 0.79 (0.75–0.84)
 Cholestatic 0.74 (0.69–0.80)
 Autoimmune 0.83 (0.72–0.94)
 Other 0.97 (0.88–1.06)
Listing laboratory MELD score 1.09 (1.08–1.10) <0.001
Blood type <0.001
 O 1
 A 1.05 (0.99–1.12)
 B 0.93 (0.84–1.02)
 AB 0.83 (0.73–0.94)

HR, hazard ratio; MELD, Model for End-Stage Liver Disease; POPH, portopulmonary hypertension.

Reference (9).

1

Adjusted for age, sex, race/ethnicity, age at listing, primary diagnosis, listing laboratory MELD score and blood type.